Erythropoietin - Albumin Platelet-rich Fibrin in Transcrestal Sinus Lifting With Simultaneous Implant Placement
Recruiting
N/A
Interventional Study
Sinus Lifting
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 20 – 60
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 20 (estimated)
- Sponsor
- Alexandria University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Background: Dental implant therapy in the posterior maxilla may be difficult owing to limited bone height after dental extraction with sinus pneumatization. Several approaches for sinus floor elevation have been documented, and hence trans crestal sinus lifting with albumin platelet rich plasma.
Aim of the study: To compare between erythropoietin and albumin platelet rich fibrin transcrestal sinu…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Residual bone height not less than 5 mm measured from crestal bone to sinus floor.
* Both genders.
* Good oral hygiene
* No previous surgery or radiation treatment on the maxillary sinus
Exclusion Criteria:
* Recent radiation therapy in maxilla.
* Uncontrolled systemic disea…
Contacts